Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001200623 | SCV001371631 | uncertain significance | not provided | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001267130 | SCV001445311 | uncertain significance | Inborn genetic diseases | 2021-11-17 | criteria provided, single submitter | clinical testing | The c.4300C>T (p.R1434W) alteration is located in coding exon 27 of the CACNA1A gene. This alteration results from a C to T substitution at nucleotide position 4300, causing the arginine (R) at amino acid position 1434 to be replaced by a tryptophan (W). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. This missense alteration is located in a region that has a low rate of benign missense variation (Lek, 2016; Firth, 2009). This alteration is predicted to be deleterious by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Neurometabolic Diseases Laboratory, |
RCV003387972 | SCV003920747 | uncertain significance | Spinocerebellar ataxia type 6 | 2023-04-27 | criteria provided, single submitter | research |